Clinical Escalation Services

The standard desk deliverable. A fixed 12-section physician memo that maps the denied case to the criteria the payer reviewer actually applied — producing handoff-ready reasoning your appeal writer can use directly. Covers inpatient medical-necessity, short-stay, and specialty denials across all appeal levels.

• Case denied on medical-necessity grounds
• Internal team has reviewed and cannot construct the clinical argument
• Appeal needs criteria-mapped reasoning beyond narrative
• Level 2 or external review requires a materially different argument

Appealability verdict · Payer rationale analysis · Clinical facts that matter · Where the denial logic is weak · Criteria-style argument · Documentation gaps · Appeal-writer instructions · Risk-of-failure assessment.

When a payer retrospectively downgrades an inpatient admission to observation status, the required argument is prospective: demonstrating that the admitting physician's expectation of a two-midnight inpatient stay was clinically reasonable at the time of admission — given the clinical picture as presented at admission, not in retrospect.

Payers look for physician-authored justification mapped to Two-Midnight Rule criteria. A retrospective summary that explains why the patient was sick does not satisfy this standard. The required argument maps the clinical picture at admission time to the admitting physician's reasonable expectation.

Hospital revenue-cycle teams, case-management departments, and RCM companies where observation-status downgrades are a systematic payer strategy — one of the most common payer tactics and one of the most consistently under-argued categories.

Paid-but-downgraded DRG claims never appear in denial dashboards because the claim was paid at a lower rate, not denied outright. Clinovian constructs the clinical-coding crossover argument — full chart reconstruction with severity markers, timestamp precision, and coding-principle framing — that complements your CDI team's work.

• 870/871 — Sepsis ($10K–$25K delta)
• 291/293 — Heart Failure ($4K–$8K)
• 003/004 — ECMO/Trach ($20K–$40K)
• 460/461 — Spinal Fusion ($6K–$12K)
• 329/331 — Major Bowel ($8K–$15K)

Chart reconstruction, severity-marker extraction with timestamps, payer-auditor point-by-point rebuttal, and coding-principle-aware argument framework. Designed to integrate with CDI workflows, not replace them.

Post-acute prior-authorization and continued-stay denials — particularly in Medicare Advantage — represent a category that has been specifically scrutinized in federal oversight reports for high appeal-overturn patterns. These denials are criteria-heavy, clinically fact-sensitive, and frequently disputed on appeal. Clinovian provides physician-level criteria mapping for these cases.

Post-acute denials are under active federal scrutiny. The criteria applied by payers and their contractors in this category are precisely the kind Clinovian's team reviewed across 3,000+ cases in payer-side utilization management — making this the desk's strongest natural territory.

• SNF admission/continued-stay denials
• IRF medical-necessity disputes
• LTACH admission and extended-stay denials
• Home health prior-authorization denials
• MA plan post-acute criteria challenges

A criteria-mapped physician briefing document for a scheduled peer-to-peer call with a payer medical director. The treating physician knows the patient — Clinovian provides the payer's decision logic, the criteria being applied, and the clinical counterarguments the reviewer will recognize.

• Applied criteria pathway and likely denial logic
• Chart evidence mapped to each criterion
• Prepared counterarguments for payer objections
• Fallback argument lines for escalation within the call
• 4–8 page structured physician briefing

P2P calls are lost when the treating physician walks in with a clinical story and the reviewer is evaluating criteria-specific evidence. These are different evaluations. Clinovian closes the gap between what the physician knows and what the reviewer needs to hear.

Independent physician review of AI-drafted appeal arguments before submission. AI appeal tools can draft quickly — but they hallucinate clinical claims, miss comorbidities, and overstate. This is a clinical quality-control layer on top of AI, not a competing appeal service.

• Hallucinated clinical claims
• Weak or unsupported criteria logic
• Missing contraindications/comorbidities
• Generic, non-case-specific language
• Payer-policy mismatch
• Overstatement risk

AI appeal-letter startups, AI-RCM vendors, and denial-automation platforms integrating physician QA into their pipeline. Per-batch or retainer.